However, few respondents correctly identified the role of Lp(a) in atherosclerosis (9%), and useful strategies for managing elevated Lp(a) (8%), including lipid-lowering therapies that could lower Lp(a) by more than 20% (12%). The gene discussed is LPA; the disease is atherosclerosis.